4//SEC Filing
Combs Andrew 4
Accession 0001562180-23-001169
CIK 0001678660other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:08 PM ET
Size
5.7 KB
Accession
0001562180-23-001169
Insider Transaction Report
Form 4
Combs Andrew
Chief Chemistry Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-02-07+135,000→ 135,000 totalExercise: $7.20Exp: 2033-02-06→ Common Stock (135,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the total shares on February 7, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Prelude Therapeutics Inc
CIK 0001678660
Entity typeother
Related Parties
1- filerCIK 0001825005
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 4:08 PM ET
- Size
- 5.7 KB